Selective small-molecule inhibition of an RNA structural element
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ribocil binding inhibits translation of ribB transcript in E. coli, inducing cell death by riboflavin starvation.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“a high throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, called “ribocil”, that targets a regulatory non-coding region (i.e. riboswitch) in the mRNA of a synthase involved in the pathway, ribB [123].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
In the citing paper
“ribocil administration, although only at high concentrations, significantly reduced bacterial burden in a mouse model of systemic infection with E. coli”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [123]
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Self-citationBad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,697
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Research works printed but not linked: 2
- Kodali, S. et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J. Biol. Chem. 280, 1669–1677 (2005) · DOI
- Bricogne, G. et al. BUSTER version 2.11.5 http://www.globalphasing.com (2014)
Cited by
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“Moreover, a high-throughput screening of small molecules recently identified an inhibitor of riboflavin synthesis, ‘ribocil’, that targets a regulatory non-coding region (i.e., riboswitch) in the mRNA for a synthase involved in the pathway, RibB [123].”
BackgroundInfluentialPrinciples for targeting RNA with drug-like small molecules
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.93 · Cited by 749
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
Targeting RNA structures with small molecules
Childs-Disney, J. L., Yang, X., Gibaut, Q. M. R., Tong, Y., Batey, R. T., & Disney, M. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00521-4 · Cited by 587
RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview
Šponer, J., Bussi, G., Krepl, M., Banáš, P., Bottaro, S., Cunha, R. A., Gil-Ley, A., Pinamonti, G., Poblete, S., Jurečka, P., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00427 · Cited by 599
“Richard Andre ́ Cunha (1989) received his undergraduate degree in”
BackgroundLong Noncoding RNA in Cancer: Wiring Signaling Circuitry
Lin, C., & Yang, L. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.008 · Cited by 488
Riboswitch diversity and distribution
McCown, P. J., Corbino, K. A., Stav, S., Sherlock, M. E., & Breaker, R. R. (2017) · RNA · doi:10.1261/rna.061234.117 · Cited by 467
“Specifically, a proposed riboswitch for aminoglycoside antibiotics (Jia et al. 2013) is most likely a previously studied DNA element exclusively associated with integrons (Roth and Breaker 2013).”
BackgroundRNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Yu, A.-M., Choi, Y. H., & Tu, M.-J. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019554 · Cited by 395
“Thus far, a number of strategies have been developed and used to design and/or identify small molecules that can bind to RNA targets, such as binding- or phenotype-based screening (Mei et al., 1997; Sztuba-Solinska et al., 2014; Howe et al., 2015; Prado et al., 2016; Rizvi et al., 2018; Velagapudi et al., 2018; Green…”
BackgroundInfluentialWeb 3DNA 2.0 for the analysis, visualization, and modeling of 3D nucleic acid structures
Li, S., Olson, W. K., & Lu, X.-J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz394 · Cited by 343
“The 3DNA ‘mutate bases’ program has already been employed in the literature for inference of statistical protein–DNA potentials (36) and homology modeling of the Escherichia coli FMN aptamer (37).”
MethodThe Emerging Role of RNA as a Therapeutic Target for Small Molecules
Connelly, C. M., Moon, M. H., & Schneekloth, J. S. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.05.021 · Cited by 316
“In another example, researchers at the Merck Research Laboratories used a phenotypic assay to discover a riboswitch-binding small molecule.(Howe et al., 2015) The concept of targeting riboswitches has been a long-standing goal since their initial discovery in 2002, (Blount and Breaker, 2006; Winkler et al.”
InfluentialDiscovering riboswitches: the past and the future
Kavita, K., & Breaker, R. R. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.08.009 · Cited by 249
Targeting RNA with small molecules: from fundamental principles towards the clinic
Falese, J. P., Donlic, A., & Hargrove, A. E. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01261k · Cited by 241
Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens
Saxena, D., Maitra, R., Bormon, R., Czekanska, M., Meiers, J., Titz, A., Verma, S., & Chopra, S. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00016-1 · Cited by 217
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Pencik, J., Pham, H. T. T., Schmoellerl, J., Javaheri, T., Schlederer, M., Culig, Z., Merkel, O., Moriggl, R., Grebien, F., & Kenner, L. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.017 · Cited by 215
“demonstrated that Ribocil, a highly selective chemical modulator of flavin, specifically represses non-coding RNA structures located in messenger RNAs [31].”
BackgroundPrecise small-molecule recognition of a toxic CUG RNA repeat expansion
Rzuczek, S. G., Colgan, L. A., Nakai, Y., Cameron, M. D., Furling, D., Yasuda, R., & Disney, M. D. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2251 · Cited by 209
Duplexed aptamers: history, design, theory, and application to biosensing
Munzar, J. D., Ng, A., & Juncker, D. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00880a · Cited by 205
Disney, M. D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13419 · Cited by 203
RNA Structure: Advances and Assessment of 3D Structure Prediction
Miao, Z., & Westhof, E. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-034125 · Cited by 188
“Examples include the well-known Purine riboswitch (27), TPP riboswitch (100), SAM riboswitch (65), FMN riboswitch (31, 90), and glmS ribozyme (36).”
BackgroundA small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier
Hart, E. M., Mitchell, A. M., Konovalova, A., Grabowicz, M., Sheng, J., Han, X., Rodriguez-Rivera, F. P., Schwaid, A. G., Malinverni, J. C., Balibar, C. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912345116 · Cited by 189
“coli strain deficient for efflux and OM integrity (13, 14).”
BackgroundSelf-citationThinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis
Lakemeyer, M., Zhao, W., Mandl, F. A., Hammann, P., & Sieber, S. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804971 · Cited by 169
How We Think about Targeting RNA with Small Molecules
Costales, M. G., Childs-Disney, J. L., Haniff, H. S., & Disney, M. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01927 · Cited by 164
Dersch, P., Khan, M. A., Mühlen, S., & Görke, B. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00803 · Cited by 172
“Approaches using synthetic mimics of the natural ligands further demonstrated that riboswitches are druggable by synthetic chemistry (Howe et al., 2015).”
BackgroundSmall molecules targeting viral RNA
Hermann, T. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1373 · Cited by 154
“has been identified in an unbiased phenotypic screen as the target for a new class of antibiotic lead compounds.(119) This wonderful example of modern antibiotic discovery promises an exciting future for RNA targets emerging in the exploration of novel therapies for bacterial and viral infections.”
BackgroundAntibiotic Resistance: Current Perspectives
Petchiappan, A., & Chatterji, D. (2017) · ACS Omega · doi:10.1021/acsomega.7b01368 · Cited by 159
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer
Diamantopoulos, M. A., Tsiakanikas, P., & Scorilas, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.06.10 · Cited by 148
The Untranslated Regions of mRNAs in Cancer
Schuster, S. L., & Hsieh, A. C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.011 · Cited by 165
Chemical Targeting of a G-Quadruplex RNA in the Ebola Virus L Gene
Wang, S., Zhang, Q., Wang, J., Ge, X., Song, Y., Wang, Y., Li, X., Fu, B., Xu, G., Shu, B., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.019 · Cited by 136
Targeting Xist with compounds that disrupt RNA structure and X inactivation
Aguilar, R., Spencer, K. B., Kesner, B., Rizvi, N. F., Badmalia, M. D., Mrozowich, T., Mortison, J. D., Rivera, C., Smith, G. F., Burchard, J., et al. (2022) · Nature · doi:10.1038/s41586-022-04537-z · Cited by 146
Mechanistic studies of a small-molecule modulator of SMN2 splicing
Wang, J., Schultz, P. G., & Johnson, K. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800260115 · Cited by 136
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model
Angelbello, A. J., Rzuczek, S. G., Mckee, K. K., Chen, J. L., Olafson, H., Cameron, M. D., Moss, W. N., Wang, E. T., & Disney, M. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901484116 · Cited by 122
“Historically, small molecules that target RNA structure have been limited to the bacterial ribosome (4, 5) and riboswitches (6).”
BackgroundTargeting RNA in mammalian systems with small molecules
Donlic, A., & Hargrove, A. E. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1477 · Cited by 130
“…resulted from a phenotypic screening campaign conducted by Merck, which led to a surprising discovery of a small molecule inhibitor of a bacterial riboflavin riboswitch, one of the first riboswitch-targeting ligands with an antibacterial effect in a mouse septicaemia model (Howe et al., 2015).”
BackgroundIdentification of RNA structures and their roles in RNA functions
Cao, X., Zhang, Y., Ding, Y., & Wan, Y. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00748-6 · Cited by 150
“These examples include molecules against the HIV RNA trans -activation response (TAR) 220 and the RRE 221 that inhibit HIV genome replication, and molecules against bacterial riboswitches such as the flavin mononucleotide (FMN)-binding riboswitch which prevents bacteria FMN sensing and growth 222 .”
New RNA-seq approaches for the study of bacterial pathogens
Saliba, A., Santos, S. C., & Vogel, J. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.01.001 · Cited by 135
Long noncoding RNAs in regulating adipogenesis: new RNAs shed lights on obesity
Wei, S., Du, ., Jiang, Z., Hausman, G. J., Zhang, L., & Dodson, M. V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2169-2 · Cited by 112
“Notably, a new discovered drug ribocil is a synthetic small molecule selectively targeting riboswitches (the specific non-coding RNA structures) in mRNAs, indicating that non-coding RNA structural elements may successfully be targeted by synthetic small molecules [60].”
BackgroundHigh-performance virtual screening by targeting a high-resolution RNA dynamic ensemble
Ganser, L. R., Lee, J. H., Rangadurai, A., Merriman, D. K., Kelly, M. L., Kansal, A. D., Sathyamoorthy, B., & Al‐Hashimi, H. M. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0062-4 · Cited by 116
“The discovery of regulatory non-coding RNAs (ncRNAs) has been accompanied by a growing interest in targeting RNA using small molecules for therapeutics development 1–5 .”
The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods
Wagner, B. K., & Schreiber, S. L. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.11.008 · Cited by 111
“Howe et al. (2015) focused on riboflavin biosynthesis by targeting flavin mononucleotide (FMN) riboswitches in Escherichia coli, which regulate riboflavin uptake and synthesis.”
Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
Zhao, R., Fu, J., Zhu, L., Chen, Y., & Liu, B. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01230-6 · Cited by 113
Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry
Rizvi, N. F., Howe, J. A., Nahvi, A., Klein, D. J., Fischmann, T. O., Kim, H., McCoy, M. A., Walker, S. S., Hruza, A. W., Richards, M. P., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b01013 · Cited by 114
Self-citationRiboswitches as Drug Targets for Antibiotics
Panchal, V. N., & Brenk, R. (2021) · Antibiotics · doi:10.3390/antibiotics10010045 · Cited by 110
“Indeed, in roseoflavin-resistant mutants, mutations are found in the FMN riboswitch aptamer domain and flavoenzymes [39,62].”
BackgroundExploring new targets and chemical space with affinity selection-mass spectrometry
Prudent, R., Annis, D. A., Dandliker, P. J., Ortholand, J.-Y., & Roche, D. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00229-2 · Cited by 104
Small molecule approaches to targeting RNA
Kovachka, S., Panosetti, M., Grimaldi, B., Azoulay, S., Giorgio, A. D., & Duca, M. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00569-9 · Cited by 112
“3g) marks a substantial shift towards specific RNA binders with drug-like properties 49 .”
Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria
Muñoz, K. A., & Hergenrother, P. J. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00895 · Cited by 103
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
Theuretzbacher, U., Blasco, B., Duffey, M., & Piddock, L. J. V. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00791-6 · Cited by 116
A Review of Antibacterial Candidates with New Modes of Action
Butler, M. S., Vollmer, W., Goodall, E. C. A., Capon, R. J., Henderson, I. R., & Blaskovich, M. A. T. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00218 · Cited by 112
Disciplined approach to drug discovery and early development
Plenge, R. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2608 · Cited by 101
SPRINT: a Cas13a-based platform for detection of small molecules
Iwasaki, R. S., & Batey, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa673 · Cited by 104
“This can include targeting riboswitches (66,82– 84, 93) , transcription factors ( 94”
InfluentialA comprehensive and quantitative exploration of thousands of viral genomes
Mahmoudabadi, G., & Phillips, R. (2018) · eLife · doi:10.7554/elife.31955 · Cited by 117
Riboflavin as a promising antimicrobial agent? A multi-perspective review
Farah, N., Chin, V. K., Chong, P. P., Lim, W. F., Lim, J. C. W., Basir, R., Chang, S. K., & Lee, T. Y. (2022) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2022.100111 · Cited by 111
Riboswitches: From living biosensors to novel targets of antibiotics
Aghdam, E. M., Hejazi, M. S., & Barzegar, A. (2016) · Gene · doi:10.1016/j.gene.2016.07.035 · Cited by 100
Challenges and current status of computational methods for docking small molecules to nucleic acids
Luo, J., Wei, W., Waldispühl, J., & Moitessier, N. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.046 · Cited by 107
Connelly, C. M., Numata, T., Boer, R. E., Moon, M. H., Sinniah, R., Barchi, J. J., Ferré-D’Amaré, A. R., & Schneekloth, J. S. (2019) · Nature Communications · doi:10.1038/s41467-019-09493-3 · Cited by 104
Mass Spectrometry of Nucleic Acid Noncovalent Complexes
Largy, E., König, A., Ghosh, A., Ghosh, D., Benabou, S., Rosu, F., & Gabelica, V. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00386 · Cited by 106
Wicks, S. L., & Hargrove, A. E. (2019) · Methods · doi:10.1016/j.ymeth.2019.04.018 · Cited by 103
Wang, H., Mann, P. A., Xiao, L., Gill, C., Galgoci, A. M., Howe, J. A., Villafania, A., Barbieri, C. M., Malinverni, J. C., Sher, X., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.03.014 · Cited by 91
“…ribocil-C (Figure 1), a small-molecule synthetic mimic of FMN that binds the FMN riboswitch of multiple GN bacteria, including E. coli, Pseudomonas aeruginosa, and Acinetobacter baumannii, to inhibit ribB expression, RF synthesis, and consequently arrest bacterial growth (Howe et al., 2015, 2016).”
BackgroundMethodResultInfluentialSelf-citationQi, B., Kniazeva, M., & Han, M. (2017) · eLife · doi:10.7554/elife.26243 · Cited by 99
“Data are represented as mean ±SD. (C) HPLC-UV analysis of VB2 extracted from worms fed live, HK-OP50 and HK-OP50+VB2 supplementation.”
BackgroundInfluentialDevelopment of Artificial Riboswitches for Monitoring of Naringenin In Vivo
Jang, S., Jang, S., Xiu, Y., Kang, T. J., Lee, S., Koffas, M. A. G., & Jung, G. Y. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00128 · Cited by 90
Chauvier, A., Picard‐Jean, F., Berger-Dancause, J.-C., Bastet, L., Naghdi, M. R., Dubé, A., Turcotte, P., Perreault, J., & Lafontaine, D. A. (2017) · Nature Communications · doi:10.1038/ncomms13892 · Cited by 87
Centromere and Pericentromere Transcription: Roles and Regulation … in Sickness and in Health
Smurova, K., & Wulf, P. D. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00674 · Cited by 93
Cai, Z., Zafferani, M., Akande, O., & Hargrove, A. E. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00254 · Cited by 92
AnnapuRNA: A scoring function for predicting RNA-small molecule binding poses
Stefaniak, F., & Bujnicki, J. M. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008309 · Cited by 86
“Some of these small molecule inhibitors include compounds such as roseoflavin [9,10] or 5FDQD [11], which are structurally similar to the natural ligand, as well as structurally dissimilar ligands having a different chemotype, for example, ribocil and its derivatives [12].”
BackgroundAmiloride as a new RNA-binding scaffold with activity against HIV-1 TAR
Patwardhan, N. N., Ganser, L. R., Kapral, G. J., Eubanks, C. S., Lee, J., Sathyamoorthy, B., Al‐Hashimi, H. M., & Hargrove, A. E. (2017) · MedChemComm · doi:10.1039/c6md00729e · Cited by 87
Small molecules that target group II introns are potent antifungal agents
Fedorova, O., Jagdmann, G. E., Adams, R. L., Yuan, L., Van Zandt, M. C., & Pyle, A. M. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0142-0 · Cited by 77
Machine Learning Informs RNA‐Binding Chemical Space**
Yazdani, K., Jordan, D., Yang, M., Fullenkamp, C. R., Calabrese, D. R., Boer, R. E., Hilimire, T. A., Allen, T. E. H., Khan, R. T., & Schneekloth, J. S. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202211358 · Cited by 91
Ligand Modulates Cross-Coupling between Riboswitch Folding and Transcriptional Pausing
Widom, J. R., Nedialkov, Y. A., Rai, V., Hayes, R. L., Brooks, C. L., Artsimovitch, I., & Walter, N. G. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.046 · Cited by 81
Long-Range Interactions in Riboswitch Control of Gene Expression
Jones, C. P., & Ferré-D’Amaré, A. R. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-034042 · Cited by 81
“Resistance mutations to the antibiotic roseoflavin and the recently developed small molecule ribocil map to residues important for tertiary contacts of the RNA fold and ligand binding (67, 68, 102).”
Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch
Motika, S. E., Ulrich, R. J., Geddes, E. J., Lee, H. Y., Lau, G. W., & Hergenrother, P. J. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c04427 · Cited by 76
Frameworks for targeting RNA with small molecules
Juru, A. U., & Hargrove, A. E. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.015203 · Cited by 79
“The discovery of ribocil occurred via a screen of 57,000 antibacterial small molecules for growth inhibition of an antibioticsensitized Escherichia coli strain in the presence or in the absence of riboflavin (118, 119).”
BackgroundLi, Y., & Disney, M. D. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00827 · Cited by 76
Howe, J. A., Xiao, L., Fischmann, T. O., Wang, H., Tang, H., Villafania, A., Zhang, R., Barbieri, C. M., & Roemer, T. (2016) · RNA Biology · doi:10.1080/15476286.2016.1216304 · Cited by 76
“To identify cognate inhibitors of RF biosynthesis, a focused library of 57,000 synthetic small molecules with intrinsic antibacterial activity was screened for compounds whose ability to inhibit bacterial growth was specifically suppressed by RF supplementation.(28)”
BackgroundMethodSelf-citationFluorescence-Based Strategies to Investigate the Structure and Dynamics of Aptamer-Ligand Complexes
Pérez‐González, C., Lafontaine, D. A., & Penedo, J. C. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00033 · Cited by 81
RNA as a small molecule druggable target
Rizvi, N. F., & Smith, G. F. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.10.052 · Cited by 84
RNA-Dependent Regulation of Virulence in Pathogenic Bacteria
Chakravarty, S., & Massé, E. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00337 · Cited by 72
Synthetic small-molecule RNA ligands: future prospects as therapeutic agents
Giorgio, A. D., & Duca, M. (2019) · MedChemComm · doi:10.1039/c9md00195f · Cited by 75
Re-engineering natural products to engage new biological targets
Motika, S. E., & Hergenrother, P. J. (2020) · Natural Product Reports · doi:10.1039/d0np00059k · Cited by 69
NLDock: a Fast Nucleic Acid–Ligand Docking Algorithm for Modeling RNA/DNA–Ligand Complexes
Feng, Y., Zhang, K., Wu, Q., & Huang, S. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00341 · Cited by 74
Structure–Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch
Vicens, Q., Mondragón, E., Reyes, F. E., Coish, P., Aristoff, P. A., Berman, J., Kaur, H., Kells, K. W., Wickens, P., Wilson, J., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00533 · Cited by 74
A ligand-gated strand displacement mechanism for ZTP riboswitch transcription control
Strobel, E. J., Cheng, L., Berman, K. E., Carlson, P. D., & Lucks, J. B. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0382-7 · Cited by 67
Shortridge, M. D., Walker, M. J. P., Pavelitz, T., Chen, Y., Yang, W. J., & Varani, G. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00180 · Cited by 77
Augmented base pairing networks encode RNA-small molecule binding preferences
Oliver, C., Mallet, V., Sarrazin‐Gendron, R., Reinharz, V., Hamilton, W. L., Moitessier, N., & Waldispühl, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa583 · Cited by 73
“For example, Ribocil, which has recently been uncovered through a phenotypic assay to target the FMN riboswitch, is currently undergoing clinical trials as a novel antibiotic [2].”
BackgroundKonovalova, A., Grabowicz, M., Balibar, C. J., Malinverni, J. C., Painter, R. E., Riley, D., Mann, P. A., Wang, H., Garlisi, C. G., Sherborne, B. S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806107115 · Cited by 65
Self-citationSmall molecule–RNA targeting: starting with the fundamentals
Hargrove, A. E. (2020) · Chemical Communications · doi:10.1039/d0cc06796b · Cited by 70
Docking and scoring for nucleic acid–ligand interactions: Principles and current status
Feng, Y., Yan, Y., He, J., Tao, H., Wu, Q., & Huang, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.10.013 · Cited by 64
Shibata, T., Nagano, K., Ueyama, M., Ninomiya, K., Hirose, T., Nagai, Y., Ishikawa, K., Kawai, G., & Nakatani, K. (2021) · Nature Communications · doi:10.1038/s41467-020-20487-4 · Cited by 71
Recent advances in RNA structurome
Xu, B., Zhu, Y., Cao, C., Chen, H., Jin, Q., Li, G., Ma, J., Yang, S. L., Zhao, J., Zhu, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2116-2 · Cited by 64
“For example, ribocil, an antibiotic that selectively targets the riboflavin riboswitch, was screened out to effectively inhibit bacterial cell growth (Howe et al., 2015).”
BackgroundInfluentialLncRNAs in Cancer: From garbage to Junk
Aprile, M., Katopodi, V., Leucci, E., & Costa, V. (2020) · Cancers · doi:10.3390/cancers12113220 · Cited by 66
Disney, M. D., Dwyer, B. G., & Childs‐Disney, J. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034769 · Cited by 68
“For example, scientists at Merck identified ribocil as targeting bacterial riboflavin riboswitches by using a phenotypic screen (Howe et al. 2015).”
MethodHARIBOSS: a curated database of RNA-small molecules structures to aid rational drug design
Panei, F. P., Torchet, R., Ménager, H., Gkeka, P., & Bonomi, M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac483 · Cited by 69
Insights into the development of chemical probes for RNA
Morgan, B. S., Forte, J. E., & Hargrove, A. E. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky718 · Cited by 63
“In one particular example, ∼57 000 ligands were screened in a growth inhibition assay against Escherichia coli with and without supplementation of riboflavin (15).”
BackgroundMethodInfluentialSmall Molecule-Based Pattern Recognition To Classify RNA Structure
Eubanks, C. S., Forte, J. E., Kapral, G. J., & Hargrove, A. E. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11087 · Cited by 59
Synthetic Biology of Small RNAs and Riboswitches
Villa, J. K., Su, Y., Contreras, L. M., & Hammond, M. C. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.rwr-0007-2017 · Cited by 60
Small molecule targeting of biologically relevant RNA tertiary and quaternary structures
Zafferani, M., & Hargrove, A. E. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.03.003 · Cited by 60
Bose, R., Saleem, I., & Mustoe, A. M. (2024) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.12.010 · Cited by 58
The Genome-Wide Interaction Network of Nutrient Stress Genes in Escherichia coli
Côté, J., French, S., Gehrke, S. S., MacNair, C. R., Mangat, C. S., Bharat, A., & Brown, E. D. (2016) · mBio · doi:10.1128/mbio.01714-16 · Cited by 55
Molecular dynamics study of the recognition of ATP by nucleic acid aptamers
Xie, Y., Eriksson, L. A., & Zhang, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa428 · Cited by 54
“4 kcal mol−1 ((2) of Figure 8) must be overcome to break the hydrogen bond between G22 and ATP; comparable to the 8.”
BackgroundSelf-citationNetworks of Resistance: Small RNA Control of Antibiotic Resistance
Mediati, D. G., Wu, S., Wu, W., & Tree, J. J. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.08.016 · Cited by 58
Chingarande, G. R., Tian, K., Kuang, Y., Sarangee, A., Hou, C., Ma, E., Ren, J., Hawkins, S., Kim, J., Adelstein, R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108118120 · Cited by 53
The yjdF riboswitch candidate regulates gene expression by binding diverse azaaromatic compounds
Li, S., Hwang, X. Y., Stav, S., & Breaker, R. R. (2016) · RNA · doi:10.1261/rna.054890.115 · Cited by 75
“It is possible to design and synthesize compounds that trick riboswitches into regulating gene expression by binding the natural ligand-binding pocket (Blount et al. 2007, 2015; Kim et al. 2009; Mulhbacher et al. 2010; Lünse et al. 2011; Howe et al. 2015).”
BackgroundSmall RNAs in Bacterial Virulence and Communication
Svensson, S. L., & Sharma, C. M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0028-2015 · Cited by 65
Hilimire, T. A., Chamberlain, J. M., Anokhina, V. S., Bennett, R. P., Swart, O., Myers, J. R., Ashton, J. M., Stewart, R. A., Featherston, A. L., Gates, K., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00052 · Cited by 54
Metalloriboswitches: RNA-based inorganic ion sensors that regulate genes
Wedekind, J. E., Dutta, D., Belashov, I. A., & Jenkins, J. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.787713 · Cited by 52
Metadata
- Authors
- Howe, J. A., Wang, H., Fischmann, T. O., Balibar, C. J., Xiao, L., Galgoci, A. M., Malinverni, J. C., Mayhood, T., Villafania, A., Nahvi, A., Murgolo, N., Barbieri, C. M., Mann, P. A., Carr, D., Xia, E., Zuck, P., Riley, D., Painter, R. E., Walker, S. S., Sherborne, B., de Jesus, R., Pan, W., Plotkin, M. A., Wu, J., Rindgen, D., Cummings, J., Garlisi, C. G., Zhang, R., Sheth, P. R., Gill, C. J., Tang, H., & Roemer, T.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Roemer, Terry
- ORCID
- Venue
- Nature
- Published
- 2015-09-30
- Volume
- 526
- Issue
- 7575
- Pages
- 672-677
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1931081986
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 15 · 2025: 40 · 2024: 43 · 2023: 34 · 2022: 38 · 2021: 35 · 2020: 39 · 2019: 43 · 2018: 42 · 2017: 40 · 2016: 35 · 2015: 2
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Institute of Microbiology, Chinese Academy of Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- riboswitches, flavin mononucleotide, non-coding RNA, riboflavin biosynthesis, antibiotic discovery, phenotypic screening
- MeSH terms
- Animals, Bacteria, Base Sequence, Escherichia coli Infections, Female, Flavin Mononucleotide, Heat-Shock Proteins, Ligands, Mice, Inbred DBA, Models, Molecular, Molecular Sequence Data, Pyrimidines, Riboflavin, RNA, Bacterial, Substrate Specificity, Reproducibility of Results, Gene Expression Regulation, Bacterial, Crystallography, X-Ray, Intramolecular Transferases, Escherichia coli Proteins, Mice, Aptamers, Nucleotide, Riboswitch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.